Welcome to The Brain Institute of America, LLC.

The Brain Institute of America was formed in 2017 with the goal of developing biomarkers for brain diseases and brain cancer. The goal is to develop effective biomarkers for those with chronic neurologic disorders as well as malignancies of the brain. The Institute is specifically focused on noncoding RNAs, a type of molecule that operates by regulating gene function. We have identified several noncoding RNAs that are highly expressed in brain tissue, and The Institute is pursuing those entities for biomarker development.

The Brain Institute of America is a biomedical research company and operates within a shared laboratory setting in Groton, CT with access to state of the art equipment and facilities. Currently we are in Phase I development which is geared towards developing biomarkers for clinical use. In phase II, curated biomarkers will be commercialized into a product for clinical testing and use.



The Institute in the news

The Brain Institute of America’s Walk for a Cure

Please click here for news on our first fundraising campaign.



The Brain Institute of America is hiring

Please click here for information on available positions.